Quantrix Revenue and Competitors

Portland, ME USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Quantrix's estimated annual revenue is currently $4.2M per year.(i)
  • Quantrix's estimated revenue per employee is $116,000

Employee Data

  • Quantrix has 36 Employees.(i)

Quantrix's People

NameTitleEmail/Phone
1
General Manager and Chief Product OfficerReveal Email/Phone
2
Quantrix Engineering ManagerReveal Email/Phone
3
QA - Test ManagerReveal Email/Phone
4
Quality Assurance AnalystReveal Email/Phone
5
Senior Marketing AssociateReveal Email/Phone
6
Software EngineerReveal Email/Phone
7
Senior Solutions ConsultantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0M2-67%$1.8MN/A
#2
$2050M5675N/AN/A$8.5B
#3
$114.9M64650%$18.3MN/A
#4
$2.1M21-12%N/AN/A
#5
$2.3M23N/AN/AN/A
#6
$0.4M6N/AN/AN/A
#7
$0.4M6N/AN/AN/A
#8
$104M585-1%$9MN/A
#9
$2.6M17N/AN/AN/A
#10
$11.1M850%$13.6MN/A
#11
$37.8M23729%N/AN/A
#12
$70.9M385-22%$300KN/A
#13
$396.1M11081%$115MN/A
#14
$0.6M8N/AN/AN/A
#15
$5.1M48-16%$1.4MN/A
#16
$0M2-33%$6.6MN/A
#17
$5.2M45N/AN/AN/A
#18
$0.5M7N/AN/AN/A
#19
$15.1M104-9%$19MN/A
#20
$1.6M23-34%$136MN/A
Add Company

What Is Quantrix?

keywords:N/A

N/A

Total Funding

36

Number of Employees

$4.2M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Quantrix News

2022-04-17 - FDA Grants Breakthrough Device Designation to Simoa ...

... immunoassay is intended to measure p-tau181 concentration in human serum and plasma using the Quantrix HD-X immunoassay system.

2022-04-13 - AeroVironment

... invasion by donating more than 100 of its Quantrix Recon drones for intelligence gathering and monitoring movement of enemy troops.

2022-04-13 - AeroVironment donates 100+ Quantrix Recon drones to Ukraine

Quantrix is a lightweight automated reconnaissance craft equipped with high-resolution, geo-referenced terrain, vegetation, and infrastructure...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.9M36-8%N/A
#2
$5.2M366%N/A
#3
$7.5M363%N/A
#4
$4.2M36N/AN/A
#5
$3.8M36-18%$33.8M